ITTO20040760A1 - USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS - Google Patents
USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSISInfo
- Publication number
- ITTO20040760A1 ITTO20040760A1 IT000760A ITTO20040760A ITTO20040760A1 IT TO20040760 A1 ITTO20040760 A1 IT TO20040760A1 IT 000760 A IT000760 A IT 000760A IT TO20040760 A ITTO20040760 A IT TO20040760A IT TO20040760 A1 ITTO20040760 A1 IT TO20040760A1
- Authority
- IT
- Italy
- Prior art keywords
- vascular
- corticosteroid
- association
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000760A ITTO20040760A1 (en) | 2004-11-03 | 2004-11-03 | USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS |
PCT/IB2005/003271 WO2006048736A1 (en) | 2004-11-03 | 2005-11-02 | Use of a corticosteroid in association with a diuretic and an antacid for the treatment of vascular stenosis and the prevention of vascular restenosis |
BRPI0517983-1A BRPI0517983A (en) | 2004-11-03 | 2005-11-02 | corticosteroid use in combination with diuretic and antacid for treatment of vascular stenosis and prevention of vascular restenosis |
EP05809315A EP1814557A1 (en) | 2004-11-03 | 2005-11-02 | Use of a corticosteroid in association with a diuretic and an antacid for the treatment of vascular stenosis and the prevention of vascular restenosis |
CA002586212A CA2586212A1 (en) | 2004-11-03 | 2005-11-02 | Use of a corticosteroid in association with a diuretic and an antacid for the treatment of vascular stenosis and the prevention of vascular restenosis |
RU2007120522/14A RU2007120522A (en) | 2004-11-03 | 2005-11-02 | USE OF A CORTICOSTEROID IN COMBINATION WITH DIURETIC AND ANTACID FOR THE TREATMENT OF VASCULAR STENOSIS AND PREVENTION OF VASCULAR RESTENOSIS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000760A ITTO20040760A1 (en) | 2004-11-03 | 2004-11-03 | USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS |
Publications (1)
Publication Number | Publication Date |
---|---|
ITTO20040760A1 true ITTO20040760A1 (en) | 2005-02-03 |
Family
ID=36051437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT000760A ITTO20040760A1 (en) | 2004-11-03 | 2004-11-03 | USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1814557A1 (en) |
BR (1) | BRPI0517983A (en) |
CA (1) | CA2586212A1 (en) |
IT (1) | ITTO20040760A1 (en) |
RU (1) | RU2007120522A (en) |
WO (1) | WO2006048736A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US8679545B2 (en) | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US20090123390A1 (en) | 2007-11-13 | 2009-05-14 | Meritage Pharma, Inc. | Compositions for the treatment of gastrointestinal inflammation |
WO2009064819A2 (en) | 2007-11-13 | 2009-05-22 | Meritage Pharma, Inc. | Compositions for the treatment of gastrointestinal inflammation |
EP2127639A1 (en) * | 2008-05-26 | 2009-12-02 | Universiteit Utrecht Holding B.V. | Corticosteroid containing liposomes for treatment of cardiovascular diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6500938B1 (en) * | 1998-01-30 | 2002-12-31 | Incyte Genomics, Inc. | Composition for the detection of signaling pathway gene expression |
AU2001273938B2 (en) * | 2000-04-12 | 2005-03-03 | Novartis Ag | Novel medical use of aldosterone synthase inhibitors alone or in combination with ati-receptor antagonists |
-
2004
- 2004-11-03 IT IT000760A patent/ITTO20040760A1/en unknown
-
2005
- 2005-11-02 CA CA002586212A patent/CA2586212A1/en not_active Abandoned
- 2005-11-02 RU RU2007120522/14A patent/RU2007120522A/en not_active Application Discontinuation
- 2005-11-02 BR BRPI0517983-1A patent/BRPI0517983A/en not_active Application Discontinuation
- 2005-11-02 EP EP05809315A patent/EP1814557A1/en not_active Withdrawn
- 2005-11-02 WO PCT/IB2005/003271 patent/WO2006048736A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2006048736A1 (en) | 2006-05-11 |
CA2586212A1 (en) | 2006-05-11 |
RU2007120522A (en) | 2008-12-10 |
BRPI0517983A (en) | 2008-10-21 |
EP1814557A1 (en) | 2007-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1830816A4 (en) | Solid dosage form comprising proton pump inhibitor and suspension made thereof | |
DK1150678T3 (en) | Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the manufacture of a medicament for the treatment of diabetic neuropathy | |
IL178012A0 (en) | Diphenyl-indol-2-on compounds and their use in the treatment of cancer | |
WO2006097535A3 (en) | Peptide agonists of the glucagon family with secretin like activity | |
DE60238422D1 (en) | OPTIMIZED DOSAGE IN PACLITAXELIC STENTS | |
CA120393S (en) | Track for display shelving | |
ATE553096T1 (en) | PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC ACTIVE INGREDIENTS | |
IL183775A0 (en) | Coated lipid complexes and their use | |
IL183664A0 (en) | Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders | |
CA112175S (en) | Dispenser | |
IL166522A0 (en) | Combination of zd6474 an inhibitor of the vascularendothelial growth factor receptor with radiother apy in the treatment of cancer | |
ITRM20050103A1 (en) | ASSOCIATION OF ANTAGONISTS OF THE INTERLEUCHINE 6 AND ANTIPROLIFERATIVE DRUGS. | |
WO2006017822A3 (en) | Quinazoline derivatives and their use in the treatment of thrombocythemia | |
DE602005022995D1 (en) | ARYLSULFONES AND ASSOCIATED USES THEREOF | |
PL2340872T3 (en) | New pharmaceutical formulations useful in the treatment of insomnia | |
ITTO20040760A1 (en) | USE OF A CORTICOSTEROID IN ASSOCIATION WITH OTHER ACTIVE PRINCIPLES FOR THE TREATMENT OF VASCULAR STENOSIS AND THE PREVENTION OF VASCULAR RESTENOSIS | |
EP1726313A4 (en) | Drug for preventing and treating arteriosclerosis | |
CA115335S (en) | Massage chair | |
IL162941A0 (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases | |
ITRM20040607A1 (en) | ANALOGUES OF THE DERMORFINA WITH ANALGESIC ACTIVITY. | |
CA115333S (en) | Massage chair | |
CA115337S (en) | Massage chair | |
ITTO20040460A1 (en) | ABSORBENT WEARABLE SANITARY PRODUCTS IN THE WAY OF A PUT AND RELATED MANUFACTURING PROCEDURE. | |
ITMO20040175A1 (en) | DEVICE FOR THE INTRODUCTION AND POSITIONING OF STENTS IN VANGI SANGUGNI. | |
AU2003244437A1 (en) | Quinoxalinones and their use especially in the treatment of cardiovascular diseases |